Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Glycosylated Gadolinium As Potential Metabolic Contrast Agent Vs Gd-Dtpa for Metabolism of Tumor Tissue in Magnetic Resonance Imaging Publisher



Heydarnezhadi S1 ; Riahi Alam N1 ; Haghgoo S2 ; Ghanaati H3 ; Khoobi M4 ; Gorji E2 ; Rafiei B3 ; Nikfar B1 ; Amirrashedi M1
Authors

Source: Applied Magnetic Resonance Published:2016


Abstract

Modern imaging technologies such as mMRI employ contrast agents to visualize the tumor microenvironment; therefore, demand for contrast agents, with an enhanced sensitivity and tissue tumor-specific target, is very high. The purpose of this study synthesizes novel metabolic contrast agent (Gd-DTPA-DG) and evaluates accumulation in tumor tissue for early diagnostic cancer. The contrast agent was synthesized and characterized with using different techniques including dynamic light scattering, high resolution transmission electron microscopy, Fourier transform infrared spectroscopy and inductively coupled plasma atomic emission spectroscopy (ICP-AES). Finally, MRI imaging performed to determine in vitro and in vivo relaxometry. Gd-DTPA-DG was specifically investigated in tissue tumor over a 45 min in vivo because of its ability to target metabolically active tumor tissue, and comparison with conventional contrast agent [Gd-DTPA (Magnevist, Bayer-USA)]. According to the result, the maximum image signal intensity in different concentrations (0.02 to approximately 0.8 mM), longitudinal relaxation time (T1) and transverse relaxation time (T2) were obtained. Signal intensity of tumor tissue was shown at 15 and 30 min after injection reaches maximum for Gd-DTPA-DG and Gd-DTPA (Magnevist, Bayer-USA), respectively. But Gd-DTPA-DG shown signal intensity higher of Gd-DTPA (Magnevist, Bayer-USA) over 45 min, comparison with Gd-DTPA (Magnevist, Bayer-USA). Images showed metabolic contrast agent penetrate into cells and accumulated in tumor. These results showed that the novel metabolic contrast agent could become a useful tool in early detection of cancer. © 2016, Springer-Verlag Wien.
Related Docs
View other Related Docs
1. In Vitro and in Vivo Studies Glycosylated Gadolinum Nanomagnetic Particleas (Gd-Dtpa-Dg) As New Potential Metabolic Contrast Agent in Mmri, IFMBE Proceedings (2015)
2. Glucosamine Conjugated Gadolinium (Iii) Oxide Nanoparticles As a Novel Targeted Contrast Agent for Cancer Diagnosis in Mri, Journal of Biomedical Physics and Engineering (2020)
3. Synthesis and Biological Evaluation of a Novel Glucosylated Derivative of Gadolinium Diethylenetriaminepentaacetic Acid for Tumor Magnetic Resonance Imaging, Iranian Journal of Pharmaceutical Research (2019)
Experts (# of related papers)
View all Related Experts
Mehdi Shafee Ardestani (7)
Hossein Ghanaati (4)
Other Related Docs
4. Dual Nano-Sized Contrast Agents in Pet/Mri: A Systematic Review, Contrast Media and Molecular Imaging (2016)
5. Correlation of Signal Intensity and Icp/Oes-Related Concentration of Gadolinium-Based Nanomagnetic Particles in Molecular Mri: In Vitro Study, Applied Magnetic Resonance (2016)
6. Properties Evaluation of Gd2o3-Deg As New Contrast Agent Nanomagnetic Particles Comparing to Gd-Dtpa in Mri, IFMBE Proceedings (2015)
7. N-Acetylcysteine-Plga Nano-Conjugate: Effects on Cellular Toxicity and Uptake of Gadopentate Dimeglumine, IET Nanobiotechnology (2020)
8. Technetium-99M Chelator-Free Radiolabeling of Specific Glutamine Tumor Imaging Nanoprobe: In Vitro and in Vivo Evaluations, International Journal of Nanomedicine (2018)
9. Abbreviated Breast Mri for Evaluating Breast Cancer Before Initiation of Neoadjuvant Chemotherapy: A Cross-Sectional Study, European Journal of Radiology Open (2023)
10. Novel Gd-Dtpa-Peptide for Targeted Breast Tumor Magnetic Resonance Imaging, Biomedicine and Pharmacotherapy (2024)
11. Gadolinium (Iii) Oxide Nanoparticles Coated With Folic Acid-Functionalized Poly(Β-Cyclodextrin-Co-Pentetic Acid) As a Biocompatible Targeted Nano-Contrast Agent for Cancer Diagnostic: In Vitro and in Vivo Studies, Magnetic Resonance Materials in Physics# Biology and Medicine (2019)
12. Synthesis and Characterization of Amlodipine-Conjugated Gd3+-Citric Acid Peg Dendrimers for Enhanced Cardiac Mri Contrast, Journal of Molecular Structure (2025)
13. Theranostic Rgd@Fe3o4-Au/Gd Nps for the Targeted Radiotherapy and Mr Imaging of Breast Cancer, Cancer Nanotechnology (2023)
14. Gd-Based Nanoparticles Mediated Magnetic Field Enhancement Inside Homogenous Tissue: Simulation Using Finite Element Method, IFMBE Proceedings (2015)
15. 18F-Fdg Micropet and Mri Targeting Breast Cancer Mouse Model With Designed Synthesis Nanoparticles, Journal of Nanomaterials (2022)
16. New Nanoprobe for Breast Cancer Cell Imaging Based on Low-Density Lipoprotein, Artificial Cells# Nanomedicine and Biotechnology (2020)
17. In Vitro and in Vivo Toxicity and Histopathological Evaluation of Gd(Iii)Anionic Linear Globular Dendrimer Second-Generation G2-C595 Nanoprobe, Nanomedicine Journal (2020)
18. Gd3+-Asparagine-Anionic Linear Globular Dendrimer Second-Generation G2 Complexes: Novel Nanobiohybrid Theranostics, Contrast Media and Molecular Imaging (2017)
19. Folic Acid Decorated Mesoporous Silica Nanospheres Loaded With Gadolinium for Breast Cancer Cell Imaging, Advances in Natural Sciences: Nanoscience and Nanotechnology (2020)
20. Evaluation of Contrast to Noise Ratio of Targeted and Non-Targeted Gold Nanoparticles in Nasopharyngeal Cancer Cells in Ct Images, Iranian Journal of Medical Physics (2023)